These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8137949)

  • 1. The oxidation of low density lipoprotein by cells or iron is inhibited by zinc.
    Wilkins GM; Leake DS
    FEBS Lett; 1994 Mar; 341(2-3):259-62. PubMed ID: 8137949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions.
    Sparrow CP; Olszewski J
    J Lipid Res; 1993 Jul; 34(7):1219-28. PubMed ID: 8103788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of low density lipoprotein by bovine and porcine aortic endothelial cells and porcine endocardial cells in culture.
    Morgan J; Smith JA; Wilkins GM; Leake DS
    Atherosclerosis; 1993 Sep; 102(2):209-16. PubMed ID: 8251007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid.
    Mangiapane H; Thomson J; Salter A; Brown S; Bell GD; White DA
    Biochem Pharmacol; 1992 Feb; 43(3):445-50. PubMed ID: 1540202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution.
    Kritharides L; Jessup W; Dean RT
    Arch Biochem Biophys; 1995 Oct; 323(1):127-36. PubMed ID: 7487058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of low density lipoprotein by iron or copper at acidic pH.
    Morgan J; Leake DS
    J Lipid Res; 1995 Dec; 36(12):2504-12. PubMed ID: 8847477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.
    Heinecke JW; Rosen H; Chait A
    J Clin Invest; 1984 Nov; 74(5):1890-4. PubMed ID: 6501577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid can either increase or decrease low density lipoprotein modification.
    Stait SE; Leake DS
    FEBS Lett; 1994 Mar; 341(2-3):263-7. PubMed ID: 8137950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein.
    Yoshida H; Ishikawa T; Hosoai H; Suzukawa M; Ayaori M; Hisada T; Sawada S; Yonemura A; Higashi K; Ito T; Nakajima K; Yamashita T; Tomiyasu K; Nishiwaki M; Ohsuzu F; Nakamura H
    Biochem Pharmacol; 1999 Dec; 58(11):1695-703. PubMed ID: 10571243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein.
    Mazière C; Auclair M; Ronveaux MF; Salmon S; Santus R; Mazière JC
    Atherosclerosis; 1991 Aug; 89(2-3):175-82. PubMed ID: 1793445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages.
    He Y; Kwan WC; Steinbrecher UP
    Atherosclerosis; 1996 Jan; 119(1):107-118. PubMed ID: 8929252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages.
    Lamb DJ; Mitchinson MJ; Leake DS
    FEBS Lett; 1995 Oct; 374(1):12-6. PubMed ID: 7589497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein.
    Malo-Ranta U; Ylä-Herttuala S; Metsä-Ketelä T; Jaakkola O; Moilanen E; Vuorinen P; Nikkari T
    FEBS Lett; 1994 Jan; 337(2):179-83. PubMed ID: 8287973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.
    Parthasarathy S
    J Clin Invest; 1992 May; 89(5):1618-21. PubMed ID: 1569200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
    Parthasarathy S; Barnett J; Fong LG
    Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic beta-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoproteins.
    Mazière C; Auclair M; Mazière JC
    Biochim Biophys Acta; 1992 Jun; 1126(3):314-8. PubMed ID: 1353372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for oxidation of low-density lipoprotein by thiols.
    Wood JL; Graham A
    FEBS Lett; 1995 Jun; 366(1):75-80. PubMed ID: 7789522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.
    Exner M; Hermann M; Hofbauer R; Kapiotis S; Speiser W; Held I; Seelos C; Gmeiner BM
    FEBS Lett; 2000 Mar; 470(1):47-50. PubMed ID: 10722843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists prevent monocyte and endothelial cell-induced modification of low density lipoproteins.
    Breugnot C; Mazière C; Auclair M; Mora L; Ronveaux MF; Salmon S; Santus R; Morlière P; Lenaers A; Mazière JC
    Free Radic Res Commun; 1991; 15(2):91-100. PubMed ID: 1756990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.